Valsts: Amerikas Savienotās Valstis
Valoda: angļu
Klimata pārmaiņas: NLM (National Library of Medicine)
KETOCONAZOLE (UNII: R9400W927I) (KETOCONAZOLE - UNII:R9400W927I)
State of Florida DOH Central Pharmacy
KETOCONAZOLE
KETOCONAZOLE 200 mg
ORAL
PRESCRIPTION DRUG
Ketoconazole tablets are indicated for the treatment of the following systemic fungal infections: candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. Ketoconazole tablets should not be used for fungal meningitis because it penetrates poorly into the cerebral-spinal fluid. Ketoconazole tablets are also indicated for the treatment of patients with severe recalcitrant cutaneous dermatophyte infections who have not responded to topical therapy or oral griseofulvin, or who are unable to take griseofulvin. Coadministration of terfenadine or astemizole with ketoconazole tablets is contraindicated. (See BOX WARNING, WARNINGS, and PRECAUTIONS.) Concomitant administration of ketoconazole tablets with cisapride is contraindicated. (See BOX WARNING, WARNINGS and PRECAUTIONS.) Concomitant administration of ketoconazole tablets with oral triazolam is contraindicated. (See PRECAUTIONS.) Ketoconazole is contrain
Ketoconazole Tablets, USP are available containing 200 mg of ketoconazole, USP. The 200 mg tablet is a white to off-white round tablet debossed with M above the score and 261 below the score on one side of the tablet and blank on the other side. They are supplied by State of Florida DOH Central Pharmacy as follows: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light and moisture. Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A. www.mylan.com This Product was Repackaged By: State of Florida DOH Central Pharmacy 104-2 Hamilton Park Drive Tallahassee, FL 32304 United States
Abbreviated New Drug Application
KETOCONAZOLE - KETOCONAZOLE TABLET STATE OF FLORIDA DOH CENTRAL PHARMACY ---------- WARNING When used orally, ketoconazole has been associated with hepatic toxicity, including some fatalities. Patients receiving this drug should be informed by the physician of the risk and should be closely monitored. (See WARNINGS and PRECAUTIONS.) Coadministration of terfenadine with ketoconazole tablets is contraindicated. Rare cases of serious cardiovascular adverse events, including death, ventricular tachycardia and Torsades de pointes have been observed in patients taking ketoconazole tablets concomitantly with terfenadine, due to increased terfenadine concentrations induced by ketoconazole tablets. (See CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS.) Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals. Coadministration of astemizole with ketoconazole tablets is therefore contraindicated. (See CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS.) Coadministration of cisapride with ketoconazole is contraindicated. Serious cardiovascular adverse events including ventricular tachycardia, ventricular fibrillation and Torsades de pointes have occurred in patients taking ketoconazole concomitantly with cisapride. (See CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS.) DESCRIPTION Ketoconazole tablets, USP are a synthetic broad spectrum antifungal agent available in scored white tablets, each containing 200 mg ketoconazole base for oral administration. In addition, each tablet also contains the following inactive ingredients: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone and corn starch. Ketoconazole is _cis_-1-acetyl-4-[4-[[2- (2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxyl]phenyl] piperazine. Ketoconazole, USP is a white to slightly beige, odorless powder, soluble in acids, with a molecular Izlasiet visu dokumentu